Drawing for CARELEAVES

USPTO serial 79226233

CARELEAVES

Reviewed by CopyMark Law Group

Reg. 5572741Status 709
Filing date
Status date
Registration date
Oct 2, 2018
Examiner
HUSSAIN, TASNEEM
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CARELEAVES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lawrence E. Abelman

Lawrence E. Abelman Abelman Frayne & Schwab666 Third Avenue10th FloorNew York, NY 10017

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical, veterinary, and sanitary preparations, namely, pharmaceutical preparations for wounds; oiled paper for medical purposes; wrapping wafers for medicine doses, namely, drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for medical purposes; empty capsules for pharmaceuticals;ear bandages; eye patches for medical purposes; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; sticking plasters for medical use; adhesive plasters for medical purposes; sticking plasters for medical purposes; bandages for dressings; antiseptic liquid bandages; self-adhesive tapes for medical purposes; adhesive tapes for medical purposes; wound dressings; adhesive patches for medical purposes, namely, wound dressings; bandages for skin wounds; poultices; anti-inflammatory drugs; pain killing drugs; antiphlogistic analgesics; moleskin for medical purposes; patches containing antiphlogistic analgesics; percutaneous absorption type adhesive skin patch agent, namely, transdermal patches for use in the treatment of skin diseases; skin patch agent for medical purposes, namely, anti-infectives; adhesive tapes containing drugs, namely, medical adhesive tapes impregnated with anti-infectives; hydrogel containing agent, namely, hydrogel for medical purposes; surgical bandages; surgical dressings; compresses, namely, medicated compresses; mustard plasters; preparations for callusesSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 30, 2026INNTTOTAL INVALIDATION PROCESSED BY THE IB
Jul 13, 2026INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jul 13, 2026INPCINVALIDATION PROCESSED
Dec 25, 2025ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 18, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 18, 2025C71TCANCELLED SECTION 71
Oct 2, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 8, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Jan 17, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB
Jan 17, 2019FIMPFINAL DISPOSITION PROCESSED
Jan 2, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 2, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 20, 2018GPNXNOTIFICATION PROCESSED BY IB
Jul 17, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 17, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 4, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 4, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 27, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 13, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
May 31, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 30, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 30, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 4, 2018RFNPREFUSAL PROCESSED BY IB
Apr 13, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 13, 2018RFRRREFUSAL PROCESSED BY MPU
Apr 11, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 10, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 9, 2018DOCKASSIGNED TO EXAMINER
Feb 13, 2018MAFRAPPLICATION FILING RECEIPT MAILED
Feb 7, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 1, 2018SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Frequently asked questions

Related guidance